title: Effect of low-dose chest irradiation before chemotherapy on the rate of local failure in small-cell lung cancer.
abstract: OBJECTIVE
  To evaluate the rate of tumor recurrence within the irradiated volume after initial low-dose irradiation of limited-stage small-cell lung cancer (SCLC), to assess the tolerance of a sequential combination of low-dose chest irradiation followed by chemotherapy, and to confirm the responsiveness of limited-stage SCLC to low-dose irradiation.
  
  
  METHODS
  In this pilot study, 26 patients with limited-stage SCLC were treated by first-line 20-Gy thoracic irradiation followed 3 weeks later by chemotherapy (cisplatin, doxorubicin, and etoposide for six cycles).
  
  
  RESULTS
  We present our final results with a median follow-up of surviving patients of 7 years. The response rate to this low-dose irradiation was 83%, with an overall response rate to radiochemotherapy of 96% and a median survival of 21 months. No unexpected early or late toxicity was observed. The rate of initial isolated local failure was 8%, which compares favorably with other published series using higher doses of radiochemotherapy.
  
  
  CONCLUSIONS
  An initial chest irradiation of 20 Gy before chemotherapy could be sufficient to reduce the risk of local failure during the time of survival of patients with limited-stage SCLC. Potential advantages of this treatment may be the prevention of resistance mechanisms to radiotherapy induced by preliminary chemotherapy and a reduced radiation-induced toxicity.
authors.affiliation: Division d'Oncologie, Hôpital Cantonal Universitaire, Geneva, Switzerland.
authors.forename: P
authors.initials: P
authors.lastname: Hösli
authors.forename: H
authors.initials: H
authors.lastname: Bonnefoi
authors.forename: R O
authors.initials: RO
authors.lastname: Mirimanoff
authors.forename: B
authors.initials: B
authors.lastname: Mermillod
authors.forename: P
authors.initials: P
authors.lastname: Alberto
mesh_terms: D000368:Aged; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011879:Radiotherapy Dosage; D016019:Survival Analysis; D017211:Treatment Failure